Allylab Pharmaceuticals Private Limited

Allylab Pharmaceuticals Private Limited - business services in Mumbai, Maharashtra, India. Directors, charges & compliance details.
CIN U86100MH2023PTC399348 Incorporated 21 March 2023 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company
Data last updated
Revenue · FY 2024
₹2.62 Cr
Latest filing
Net loss · FY 2024
₹24,137
Net margin -0.1%
EBITDA · FY 2024
₹17.88 Lakh
EBITDA margin 6.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹33.66 Lakh
Secured borrowings
Company age
3 yrs
Est. 2023
Directors on board
2
As per MCA filings

About Allylab Pharmaceuticals Private Limited

Data last updated:

Allylab Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It was incorporated on 21 March 2023.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U86100MH2023PTC399348. Its GSTIN is 08AADCW4860C1ZD (Rajasthan).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jahnvi Sharma and Rashmi Bansal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2024, the company reported a revenue of ₹2.62 Cr. For the same year it recorded a net loss of ₹24,137 (net margin -0.1%) and EBITDA of ₹17.88 Lakh (EBITDA margin 6.8%).

As per MCA filings, the company has open charges of ₹33.66 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Allylab Pharmaceuticals Private Limited
CIN U86100MH2023PTC399348
Registration Number 399348
Incorporation Date 21 March 2023
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Plot No 710G Common H T K Raheja Platinum Marol Industrial Estate, Marol Industrial Estate Near Sag Baug Marol Co Op Sty, Mumbai, Maharashtra, India – 400059
Comprehensive company report
Allylab Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Allylab Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Allylab Pharmaceuticals Private Limited in one report.

Financials from FY 2023 Directors & ownership Charges & compliance

Business Activity of Allylab Pharmaceuticals Private Limited

The main business activity of Allylab Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GWholesale and retail trade; repair of motor vehicles and motorcycles47Retail trade, except of motor vehicles and motorcyclesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Allylab Pharmaceuticals Private Limited FY 2025 filings available

Allylab Pharmaceuticals Private Limited reported revenue of ₹2.62 Cr for FY 2024.

Revenue · FY 2024
₹2.62 Cr
Net loss · FY 2024
₹24,137 margin -0.1%
EBITDA · FY 2024
₹17.88 Lakh margin 6.8%

Financial Statement Summary of Allylab Pharmaceuticals Private Limited

MetricsFY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations••••••••
Other Income••••••••
Total Revenue••••••••
Cost of Materials Consumed••••••••
Employee Benefit Expense••••••••
Finance Costs••••••••
Depreciation and Amortisation••••••••
Other Expenses••••••••
Total Expenses••••••••
EBITDA₹17.88 Lakh••••
Profit Before Tax••••••••
Tax Expense••••••••
Net Profit (PAT)-₹24,137••••
Balance Sheet
Share Capital••••••••
Reserves and Surplus••••••••
Net Worth (Total Equity)••••••••
Long-term Borrowings••••••••
Short-term Borrowings••••••••
Trade Payables••••••••
Total Liabilities••••••••
Fixed Assets••••••••
Investments••••••••
Inventories••••••••
Trade Receivables••••••••
Cash and Bank Balance••••••••
Total Assets••••••••

Financial Ratios of Allylab Pharmaceuticals Private Limited

MetricsFY 2023-24FY 2022-23
Profitability
EBITDA Margin6.8%••••
Net Profit Margin-0.1%••••
Return on Equity (ROE)••••••••
Return on Capital Employed (ROCE)••••••••
Return on Assets (ROA)••••••••
Liquidity and Debt
Current Ratio••••••••
Quick Ratio••••••••
Debt-to-Equity Ratio••••••••
Interest Coverage Ratio••••••••
Efficiency and Growth
Asset Turnover••••••••
Receivable Days••••••••
Payable Days••••••••
Inventory Days••••••••
Revenue Growth••••••••
Net Profit Growth••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Allylab Pharmaceuticals are in the company report.

Premium access

Financial statements from FY 2023

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Allylab Pharmaceuticals Private Limited

Allylab Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Splenz Pharmaceuticals Private Limited₹2.66 Cr (FY 2024)••••••••21.0%••••Pune, Maharashtra, India
Xcelent Pharmaceuticals Private Limited₹2.66 Cr (FY 2025)••••••••86.0%••••Noida, Uttar Pradesh, India
GRS Pharmaceuticals Private Limited₹2.64 Cr (FY 2024)••••••••0.0%••••Mumbai, Maharashtra, India
Nark Pharmaceuticals Private Limited₹2.64 Cr (FY 2025)••••••••3.0%••••Ernakulam, Kerala, India
Nauge Pharmaceuticals Pvt Ltd₹2.63 Cr (FY 2025)••••••••-3.0%••••Telangana, India
Allylab Pharmaceuticals Private Limited this company₹2.62 Cr (FY 2024)••••••••••••Mumbai, Maharashtra, India
Diancecht Pharmaceuticals Private Limited₹2.61 Cr (FY 2023)••••••••40.0%••••Chandigarh, India
Janaxa Pharmaceuticals Private Limited₹2.6 Cr (FY 2025)••••••••10.0%••••Chandigarh, India
Torgem Pharmaceuticals Private Limited₹2.6 Cr (FY 2024)••••••••25.0%••••Navi Mumbai, Maharashtra, India
Aleta Pharmaceuticals Private Limited₹2.58 Cr (FY 2025)••••••••34.0%••••Chennai, Tamil Nadu, India
Erie Pharmaceuticals Private Limited₹2.58 Cr (FY 2025)••••••••76.0%••••Jaipur, Rajasthan, India

Peers are the five companies nearest above and the five nearest below Allylab Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Board of Directors of Allylab Pharmaceuticals Private Limited

Allylab Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Jahnvi SharmaDirector21 Mar 20233 Years 6 MonthsCurrent
Rashmi BansalDirector21 Mar 20233 Years 6 MonthsCurrent

Charges & Borrowings of Allylab Pharmaceuticals Private Limited

Open charges
₹33.66 Lakh
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹0.25 Cr
Hdfc Bank Limited₹0.09 Cr
Latest charge details
DateLenderAmountStatus
01 May 2025State Bank of India₹24.75 LakhOpen
09 Jan 2024Hdfc Bank Limited₹8.91 LakhOpen

Total charge records: 2 View all charges

Employees and EPFO Compliance at Allylab Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Allylab Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Allylab Pharmaceuticals Private Limited

Allylab Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Jahnvi Sharma was appointed as Director on 21 Mar 2023.

AGM
Allylab Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with State Bank Of India amounted to Rs. 24.75 Lakh with Charge ID 101088938 was registered on 01 May 2025.
Filing
Allylab Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 8.91 Lakh with Charge ID 100848495 was registered on 09 Jan 2024.
Appointed
Jahnvi Sharma was appointed as Director.
Appointed
Rashmi Bansal was appointed as Director.
Incorporation
21 Mar 2023
Allylab Pharmaceuticals Private Limited was registered on 21 Mar 2023 with Roc Mumbai I & aged 3 years 6 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Allylab Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Allylab Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Allylab Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Allylab Pharmaceuticals Private Limited

Allylab Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
08AADCW4860C1ZDRajasthanActive18 Apr 2023
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Allylab Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Allylab Pharmaceuticals Private Limited

Allylab Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. It was incorporated on 21 March 2023 (3+ years old) and is registered under CIN U86100MH2023PTC399348.

Allylab Pharmaceuticals reported revenue of ₹2.62 Cr for FY 2024.

Allylab Pharmaceuticals has 2 current directors:

Allylab Pharmaceuticals reported a net loss of ₹24,137 (net margin -0.1%) and EBITDA of ₹17.88 Lakh (EBITDA margin 6.8%) for FY 2024, as per its filed financial statements.

The GSTIN of Allylab Pharmaceuticals is 08AADCW4860C1ZD, registered in Rajasthan.

The CIN (Corporate Identification Number) of Allylab Pharmaceuticals is U86100MH2023PTC399348. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Allylab Pharmaceuticals was incorporated on 21 March 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Allylab Pharmaceuticals by revenue are Splenz Pharmaceuticals Private Limited, Xcelent Pharmaceuticals Private Limited, GRS Pharmaceuticals Private Limited, Nark Pharmaceuticals Private Limited, Nauge Pharmaceuticals Pvt Ltd and 5 more, all in the Pharma industry (Pharmaceuticals).

Jahnvi Sharma was appointed as Director on 21 Mar 2023. Rashmi Bansal was appointed as Director on 21 Mar 2023.

The registered office of Allylab Pharmaceuticals is at Plot No 710G Common H T K Raheja Platinum Marol Industrial Estate, Marol Industrial Estate Near Sag Baug Marol Co Op Sty, Mumbai, Maharashtra, India – 400059.

Allylab Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available